BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Policy

  TiGenix Obtains Manufacturing License for European Production Facility

  April 24, 2012

   · 

  2 min read
• Business

  EXACT Sciences Corporation to Host First-Quarter 2012 Results Webcast and Call

  April 24, 2012

   · 

  1 min read
• Drug Development

  BioTime’s Subsidiary ReCyte Therapeutics, Inc. Provides Update on Preclinical Development of Vascular Progenitors for the Treatment of Age-Related Vascular Disease

  April 24, 2012

   · 

  1 min read
• Biotech Bay

  BioTime’s Subsidiary LifeMap Sciences, Inc. Presents Update on Product Development

  April 24, 2012

   · 

  1 min read
• Business

  University of Maryland BioPark Announces MedImmune’s Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park

  April 24, 2012

   · 

  1 min read
• Business

  Array BioPharma, Inc. to Report Financial Results for the Third Quarter of Fiscal 2012 on April 30, 2012

  April 24, 2012

   · 

  1 min read
• BioMidwest

  Baxter International, Inc. to Webcast Annual Meeting of Shareholders

  April 24, 2012

   · 

  1 min read
• Business

  First-Quarter Figures: Sartorius AG Off to a Good Start in 2012

  April 24, 2012

   · 

  1 min read
• Drug Development

  R-Tech Ueno: Completion of a Phase I Clinical Study of RK-023 for the Treatment of Hypotrichosis of the Eyelashes

  April 24, 2012

   · 

  1 min read
• Business

  PsiOxus Therapeutics Limited Moves into New Facilities on Milton Park to Accommodate Expansion

  April 24, 2012

   · 

  1 min read